CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
Want to see GDTC full AI Analyst Report?
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 14, 2026 | xxxxxxxxxxxxx | $98094 | |
Feb 13, 2026 | xxxxxxxxxxxxx | $122030 | |
Oct 23, 2025 | xxxxxxxxxxxxx | $283608 | |
Sep 23, 2025 | xxxxxxxxxxxxx | $102731 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns CytoMed Therapeutics Limited (GDTC)?
Currently, no data Available
What percentage of CytoMed Therapeutics Limited (GDTC) stock is held by institutional investors?
Currently, no data Available
What percentage of CytoMed Therapeutics Limited (GDTC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of CytoMed Therapeutics Limited (GDTC)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.